Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Goodwill & Intangibles (2024 - 2025)

Historic Goodwill & Intangibles for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to $18.8 million.

  • Day One Biopharmaceuticals' Goodwill & Intangibles rose 1602.74% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 1602.74%. This contributed to the annual value of $15.6 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Goodwill & Intangibles is $18.8 million, which was up 1602.74% from $19.6 million recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Goodwill & Intangibles ranged from a high of $20.4 million in Q1 2025 and a low of $15.6 million during Q4 2024